Patents by Inventor William R. Baumbach

William R. Baumbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230191090
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for stent deployment, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Applicant: Caliber Therapeutics, LLC
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Publication number: 20210386979
    Abstract: A balloon catheter system for infusion of micelles at high pressure. The system includes a catheter with a drug eluting balloon with a perforated wall with numerous pores, a reservoir of nanoparticles in an aqueous solution disposed within the balloon or in fluid communication with the balloon. The particles may comprise drug loaded micelles, where the micelles are provided in the size range of 40 to 250 nm generally (0.040 ?m to 0.250 ?m), and the pores of the balloon wall are configured to allow passage of the micelles with a minimum of disruption, The pores are conical, with the diameter of the pore at the inside of the balloon wall smaller than the diameter of the pores at the outside of the balloon wall.
    Type: Application
    Filed: September 26, 2019
    Publication date: December 16, 2021
    Applicant: Caliber Therapeutics, LLC
    Inventors: William R. BAUMBACH, Darren R. SHERMAN
  • Publication number: 20210046292
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: October 20, 2020
    Publication date: February 18, 2021
    Applicant: Caliber Therapeutics, LLC
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 10806909
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: October 20, 2020
    Assignee: Caliber Therapeutics, LLC
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 10207084
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: February 19, 2019
    Assignee: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Publication number: 20180361124
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 20, 2018
    Applicant: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Publication number: 20170246432
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: May 12, 2017
    Publication date: August 31, 2017
    Applicant: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 9649478
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: May 16, 2017
    Assignee: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 9649479
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: May 16, 2017
    Assignee: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Publication number: 20160199624
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: March 23, 2016
    Publication date: July 14, 2016
    Applicant: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Publication number: 20140221978
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: April 7, 2014
    Publication date: August 7, 2014
    Applicant: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 8715230
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: April 2, 2013
    Date of Patent: May 6, 2014
    Assignee: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert S. Burgermeister
  • Patent number: 8696644
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: April 15, 2014
    Assignee: Caliber Therapeutics, Inc.
    Inventors: William R. Baumbach, Darren R. Sherman, Robert Burgermeister
  • Publication number: 20140039389
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: April 2, 2013
    Publication date: February 6, 2014
    Inventors: William R. Baumbach, Darren R. Sherman, Robert Burgermeister
  • Publication number: 20110166547
    Abstract: Devices and methods for balloon delivery of rapamycin and other hydrophobic compounds to the wall of blood vessels. Balloon catheters, such as those used for balloon angioplasty, are modified with the addition of a reservoir of dry micelles, disposed at a suitable location within the balloon or catheter. The reservoir may be installed within the angioplasty balloon, within a lumen in communication with the angioplasty balloon, either as a loose or packed powder or as a film coating. The micelle preparation is reconstituted and the micelles are mobilized when the aqueous solution used to inflate the balloons is injected into the catheter. The micelles are infused into tissue surrounding the balloon when pressurized fluid within the balloon leaks through the wall of the balloon.
    Type: Application
    Filed: December 30, 2010
    Publication date: July 7, 2011
    Inventors: William R. Baumbach, Darren R. Sherman, Robert Burgermeister
  • Publication number: 20090220564
    Abstract: The present disclosure provides methods and compositions for treating coronary tissue damaged as a result of a cardiac disorder such as ischemia, acute myocardial infarction, vulnerable plaques, or reperfusion injury. Specifically, the cardiac disorder is treated using a multivalent molecule that is specific for a marker located, in or near the damaged coronary tissue and a marker located on a target cell (e.g., a stem cell). The multivalent molecule may be administered by intravenous injection, intra-arterial catheter, intramyocardial injection, or implantable device (e.g, stent).
    Type: Application
    Filed: August 18, 2006
    Publication date: September 3, 2009
    Inventors: William R. Baumbach, Hariharan Shankar, Oded Ben-Joseph
  • Patent number: 6342499
    Abstract: The present invention provides a method to control parasitic and saprophagous mites on beneficial insects such as honeybees via the application of a parasiticidally or saprophagouscidally effective amount of a mitochondrial electron transport inhibitor or a pyrimidine compound of formula I.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: January 29, 2002
    Assignee: BASF Aktiengesellschaft
    Inventors: Bruce Christian Black, William R. Baumbach, Michael P. Beluch
  • Patent number: 6204283
    Abstract: The present invention provides a method to control parasitic mites on beneficial insects, such as honeybees, via the application of a parasiticidally effective amount of tebufenpyrad.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: March 20, 2001
    Assignee: American Cyanamid Company
    Inventors: Bruce Christian Black, William R. Baumbach, Michael P. Beluch
  • Patent number: 5583010
    Abstract: Growth hormone releasing hormone (GHRH) receptor binding has been characterized using a unique binding assay utilizing iodinated GHRH probes. Photoaffinity GHRH probes have been constructed which allow for photolabeling and characterization of the receptor. In addition, high affinity biotinylated GHRH analogs have been constructed. Solubilization of GHRH-R/GHRH complexes and extraction of specifically bound GHRH using a mild detergent solution, followed by affinity chromotography, leads to a substantially purified GHRH-R isolate. Electrophoretic treatment of the GHRH-R isolate produces GHRH-R of sufficient purity to conduct sequencing of the receptor. Cloning of a gene encoding for polypeptides (protein or fragments thereof) having GHRH-R activity is accomplished using a bacterial host, and the cloned gene is expressed in a mammalian cell line.
    Type: Grant
    Filed: June 10, 1993
    Date of Patent: December 10, 1996
    Assignees: American Cyanamid Company, The University of Virginia Patent Foundation
    Inventors: William R. Baumbach, John R. Zysk, Michael O. Thorner, Bruce D. Gaylinn, Kevin R. Lynch, Jeffrey K. Harrison
  • Patent number: 5439795
    Abstract: The present invention is directed to antibodies, in particular monoclonal antibodies, which specifically bind to somatotropin binding proteins of animals, but not with the corresponding somatotropin receptors. The antibodies may also be used to assay the level of somatotropin binding protein of animals.
    Type: Grant
    Filed: January 31, 1990
    Date of Patent: August 8, 1995
    Assignee: American Cyanamid Company
    Inventors: William R. Baumbach, Bosco S. Wang, Homayoun Sadeghi, John S. Logan, Ian C. Hart